-
Frontiers in Endocrinology 2023
Topics: Humans; COVID-19; Diabetic Ketoacidosis; Diabetes Mellitus
PubMed: 36726739
DOI: 10.3389/fendo.2023.1136997 -
Journal of Diabetes Research 2019
Topics: Animals; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Humans; Oxidative Stress; Reactive Oxygen Species
PubMed: 31192263
DOI: 10.1155/2019/4189813 -
JPMA. the Journal of the Pakistan... Sep 2023In this communication, we provide a bird's eye view of the various ways in which infectious diseases intersect with diabetes. We list the ways in which infectious...
In this communication, we provide a bird's eye view of the various ways in which infectious diseases intersect with diabetes. We list the ways in which infectious diseases can influence glucose homoeostasis and diabetes management, and explores how diabetes care is associated with infections and infection management. This is especially important for health care providers in regions with a high burden of infectious disease.
Topics: Humans; Diabetes Mellitus; Communicable Diseases
PubMed: 37817714
DOI: 10.47391/JPMA.23-64 -
Journal of Diabetes Investigation Nov 2022
Topics: Humans; Diabetes Mellitus; Diffusion of Innovation; China
PubMed: 36121277
DOI: 10.1111/jdi.13908 -
Ugeskrift For Laeger May 2023Maturity-onset diabetes of the young (MODY) is a group of hereditary monogenetic forms of diabetes. MODY accounts for 1-3% of all persons with diabetes but is often... (Review)
Review
Maturity-onset diabetes of the young (MODY) is a group of hereditary monogenetic forms of diabetes. MODY accounts for 1-3% of all persons with diabetes but is often undiagnosed or misdiagnosed as type 1 diabetes, type 2 diabetes, or gestational diabetes. Diagnosing MODY is essential, as the most optimal treatment both during and outside of pregnancy depends on the MODY type. This review focuses on the outcome and treatment of the three most common types of MODY during pregnancy.
Topics: Pregnancy; Female; Humans; Diabetes Mellitus, Type 2; Diabetes, Gestational; Diabetes Mellitus, Type 1; Mutation
PubMed: 37264885
DOI: No ID Found -
Experimental Diabetes Research 2012
Topics: Animals; Autonomic Nervous System; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Humans; Inflammation; Inflammation Mediators; Prognosis; Quality of Life
PubMed: 23346102
DOI: 10.1155/2012/894157 -
Clinical Medicine (London, England) Jul 2021Diabetes mellitus is a common condition which all clinicians will encounter in their clinical practice. The most common form is type 2 diabetes followed by type 1...
Diabetes mellitus is a common condition which all clinicians will encounter in their clinical practice. The most common form is type 2 diabetes followed by type 1 diabetes. However, there are many other atypical forms of diabetes which are important for a clinician to consider as it can impact on the diagnosis and their management.This article focuses on maturity onset diabetes of the young (MODY), latent autoimmune diabetes in adults (LADA), ketosis-prone diabetes and other secondary forms of diabetes such as pancreatic cancer and haemochromatosis. We briefly describe the key clinical features of these forms of diabetes and their investigations and treatment.
Topics: Autoantibodies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans
PubMed: 35192474
DOI: 10.7861/clinmed.2021-0369 -
Diabetologia Apr 2020The purpose of this review is to provide an update on the changing face of paediatric type 1 diabetes and type 2 diabetes. Paediatric diabetes is on the rise, with... (Review)
Review
The purpose of this review is to provide an update on the changing face of paediatric type 1 diabetes and type 2 diabetes. Paediatric diabetes is on the rise, with extensive research dedicated to understanding its pathophysiology, comorbidities and complications. As obesity continues to increase among all youth, differentiating between type 1 diabetes and type 2 diabetes has become increasingly difficult but remains important for optimising treatment, anticipating complications and predicting disease risk. Novel treatments are emerging, with the ultimate goal being to achieve glycaemic control, limit weight gain, improve quality of life and reduce comorbidities. In this review, we focus on updates regarding the epidemiology, clinical presentation, comorbidities and complications of paediatric type 1 diabetes and type 2 diabetes and conclude with current and emerging treatments.
Topics: Age of Onset; Child; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Endocrinology; Humans; Pediatric Obesity; Pediatrics; Risk Factors
PubMed: 31897525
DOI: 10.1007/s00125-019-05075-6 -
Nephron 2021Post-transplant diabetes mellitus (PTDM) is a frequent and relevant complication after renal transplantation: it affects 20-30% of renal transplant recipients and... (Review)
Review
Post-transplant diabetes mellitus (PTDM) is a frequent and relevant complication after renal transplantation: it affects 20-30% of renal transplant recipients and increases the risk for cardiovascular and infectious events. Thus, understanding pathogenesis of PTDM would help limiting its consequences. In this review, we analyse novel aspects of PTDM, based on studies of the last decade, such as the clinical evolution of PTDM, early and late, the reversibility rate, diagnostic criteria, risk factors, including pre-transplant metabolic syndrome and insulin resistance (IR) and the interaction between these factors and immunosuppressive medications. Also, we discuss novel pathogenic factors, in particular the role of β-cell function in an environment of IR and common pathways between pre-existing cell damage and tacrolimus-induced toxicity. The relevant role of prediabetes in the pathogenesis of PTDM and cardiovascular disease is also addressed. Finally, current evidence on PTDM treatment is discussed.
Topics: Diabetes Mellitus; Humans; Insulin Resistance; Kidney Transplantation; Prediabetic State; Transplant Recipients
PubMed: 33902027
DOI: 10.1159/000514288 -
Frontiers in Endocrinology 2021The relationship between COVID-19 and diabetes mellitus is complicated and bidirectional. On the one hand, diabetes mellitus is considered one of the most important risk... (Review)
Review
The relationship between COVID-19 and diabetes mellitus is complicated and bidirectional. On the one hand, diabetes mellitus is considered one of the most important risk factors for a severe course of COVID-19. Several factors that are often present in diabetes mellitus are likely to contribute to this risk, such as older age, a proinflammatory and hypercoagulable state, hyperglycemia and underlying comorbidities (hypertension, cardiovascular disease, chronic kidney disease and obesity). On the other hand, a severe COVID-19 infection, and its treatment with steroids, can have a specific negative impact on diabetes itself, leading to worsening of hyperglycemia through increased insulin resistance and reduced β-cell secretory function. Worsening hyperglycemia can, in turn, adversely affect the course of COVID-19. Although more knowledge gradually surfaces as the pandemic progresses, challenges in understanding the interrelationship between COVID-19 and diabetes remain.
Topics: COVID-19; Diabetes Complications; Diabetes Mellitus; Disease Progression; Humans; Pandemics; Prognosis; Risk Factors; SARS-CoV-2; Severity of Illness Index
PubMed: 34220706
DOI: 10.3389/fendo.2021.649525